Corteva, Inc. $CTVA Position Reduced by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lessened its position in Corteva, Inc. (NYSE:CTVA) by 7.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 753,399 shares of the company’s stock after selling 59,542 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Corteva were worth $63,180,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. BlackRock Inc. acquired a new stake in Corteva in the 2nd quarter valued at about $4,560,180,000. Wellington Management Group LLP increased its position in Corteva by 941.7% during the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock worth $644,720,000 after buying an additional 6,881,875 shares during the last quarter. Royal Bank of Canada increased its position in Corteva by 202.1% during the first quarter. Royal Bank of Canada now owns 7,458,624 shares of the company’s stock worth $624,362,000 after buying an additional 4,989,371 shares during the last quarter. Jupiter Topco LLC bought a new stake in Corteva in the second quarter valued at approximately $544,246,000. Finally, Bank of America Corp DE bought a new stake in Corteva in the second quarter valued at approximately $484,927,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CTVA has been the subject of a number of recent analyst reports. Zacks Research cut Corteva from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 6th. Oppenheimer set a $17.00 target price on Corteva in a research note on Monday, October 5th. New Street Research set a $17.00 target price on Corteva in a report on Monday, October 5th. Argus restated a “buy” rating and issued a $91.00 price target on shares of Corteva in a research note on Friday, September 18th. Finally, JPMorgan Chase & Co. raised Corteva from a “neutral” rating to an “overweight” rating and set a $19.00 price target for the company in a report on Tuesday, October 6th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $60.59.

Corteva Stock Up 1.2%

Shares of CTVA opened at $12.87 on Friday. The firm has a market cap of $8.59 billion, a P/E ratio of 8.52, a price-to-earnings-growth ratio of 1.78 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.10 and a current ratio of 1.52. Corteva, Inc. has a 52 week low of $11.74 and a 52 week high of $90.97. The firm’s 50-day simple moving average is $60.00 and its 200 day simple moving average is $73.83.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period last year, the business posted $2.20 earnings per share. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts forecast that Corteva, Inc. will post 1.04 earnings per share for the current year.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an agriculture company that develops and supplies products and services designed to help farmers improve crop productivity, protect yields and manage agricultural challenges. Its business is organized primarily around seed and crop protection products.

The company’s seed portfolio includes branded corn, soybean, cotton, sunflower, canola and other crop varieties, supported by plant genetics and biotechnology. Its crop protection business offers herbicides, insecticides, fungicides and seed-applied treatments, along with biological and digital agriculture solutions intended to support crop health and farm-management decisions.

Corteva was formed through the separation of the agriculture division of DowDuPont and became an independent public company in 2019.